Get started
Author

Andrea Gaetano Allegra

Observed names: A Allegra, A G Allegra, A. Allegra, A.G. Allegra, ANDREA GAETANO ALLEGRA, Andrea Allegra, Andrea G. Allegra
Observed institutions: University of Messina, Ospedale Sacro Cuore Don Calabria, Azienda Ospedaliero-Universitaria Careggi, Azienda Ospedaliera Universitaria Policlinico "G. Martino", University of Florence, University of Brescia
ORCID: 0000-0001-6109-4563
Observed ORCID: 0000-0001-6109-4563
OpenAlex ID: A5066539183
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
2017 · Caterina Musolino, Alessandro Allegra, et al. · Mediators of Inflammation · 179
PDF
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)
2023 · Giulio Francolini, Andrea Gaetano Allegra, et al. · Journal of Clinical Oncology · 146
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
2020 · Alessandro Allegra, Vanessa Innao, et al. · Annals of Hematology · 67
PDF
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw
2018 · Caterina Musolino, Giacomo Oteri, et al. · Annals of Hematology · 56
Formaldehyde Exposure and Acute Myeloid Leukemia: A Review of the Literature
2019 · Alessandro Allegra, Giovanna Spatari, et al. · Medicina · 44
PDF
Therapeutic potential of antagomiRs in haematological and oncological neoplasms
2020 · Vanessa Innao, Alessandro Allegra, et al. · European Journal of Cancer Care · 34
PDF
Nanobodies and Cancer: Current Status and New Perspectives
2018 · Alessandro Allegra, Vanessa Innao, et al. · Cancer Investigation · 34
Telomerase and telomere biology in hematological diseases: A new therapeutic target
2017 · Alessandro Allegra, Vanessa Innao, et al. · Leukemia Research · 31
Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
2019 · Alessandro Allegra, Vanessa Innao, et al. · International Journal of Molecular Sciences · 30
PDF
New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
2020 · Vanessa Innao, Andrea Gaetano Allegra, et al. · International Journal of Molecular Sciences · 25
PDF
Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity
2023 · Luca Nicosia, Paolo Ravelli, et al. · Radiotherapy and Oncology · 24
Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
2021 · Vanessa Innao, Vincenzo Rizzo, et al. · Cells · 24
PDF
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
2020 · Vanessa Innao, Vincenzo Rizzo, et al. · Current Oncology · 23
PDF
Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies
2020 · Andrea Gaetano Allegra, Federica Mannino, et al. · Antioxidants · 23
PDF
Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology
2020 · Alessandro Allegra, Vanessa Innao, et al. · Expert Review of Hematology · 23
Role of the microbiota in hematologic malignancies.
2019 · A Allegra, V Innao, et al. · PubMed · 23
Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate‐Induced Osteonecrosis of the Jaw
2020 · Alessandro Allegra, Manuela Mania, et al. · BioMed Research International · 20
PDF
Selective Inhibitors of Nuclear Export in the Treatment of Hematologic Malignancies
2019 · Alessandro Allegra, Vanessa Innao, et al. · Clinical Lymphoma Myeloma & Leukemia · 19
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
2019 · Alessandro Allegra, Caterina Musolino, et al. · Antioxidants · 16
PDF
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years
2021 · G. Francolini, M. Loi, et al. · Clinical Oncology · 14
SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma
2021 · Alessandro Allegra, Vanessa Innao, et al. · Clinical Biochemistry · 13
Standardisation of minimal residual disease in multiple myeloma
2017 · V. Innao, A. Allegra, et al. · European Journal of Cancer Care · 13
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy
2022 · Giulio Francolini, Giulio Frosini, et al. · Journal of Geriatric Oncology · 11
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)
2022 · Giulio Francolini, Beatrice Detti, et al. · La radiologia medica · 11
PDF
Three Months’ PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy—STARR (NCT05455736)
2023 · Giulio Francolini, Pietro Garlatti, et al. · Cancers · 10
PDF
Works count: 96
Citation count: 1,023
H-index: 18
I10-index: 26
Year
Topic
Type